Evidence map›Paper›PMID 40104317›Full record

ArticleTurkish journal of medical sciences2025

Impact of ivermectin on nerve regeneration following sciatic injury in mice: the consequences of dietary high fructose.

Ezgi Deniz Arikan, Barışcan Çimen, Ayşe Ece Gezen Yilmaz, Elif Akaydin, Berkay Alpay, Deniz Ekin Erbaş, Erblina Nikshiqi, Sevda F Müftüoğlu, Yıldırım Sara

Abstract read
In one paragraph

Article in Turkish journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ezgi Deniz Arikan *Department of Medical Pharmacology, Faculty of Medicine, Hacettepe University, Ankara, Turkiye.ORCID https://orcid.org/0000-0003-4546-1364
Barışcan Çimen *Department of Medical Pharmacology, Faculty of Medicine, Hacettepe University, Ankara, Turkiye.ORCID https://orcid.org/0000-0002-0705-6184
Ayşe Ece Gezen YilmazDepartment of Medical Pharmacology, Faculty of Medicine, Hacettepe University, Ankara, Turkiye.ORCID https://orcid.org/0000-0002-6444-5397
Elif AkaydinDepartment of Medical Pharmacology, Faculty of Medicine, Hacettepe University, Ankara, Turkiye.ORCID https://orcid.org/0000-0001-6916-2516
Berkay AlpayDepartment of Medical Pharmacology, Faculty of Medicine, Hacettepe University, Ankara, Turkiye.ORCID https://orcid.org/0000-0001-8531-5690
Deniz Ekin ErbaşDepartment of Histology and Embryology, Faculty of Medicine, Hacettepe University, Ankara, Turkiye.ORCID https://orcid.org/0000-0002-5077-3955
Erblina NikshiqiDepartment of Histology and Embryology, Faculty of Medicine, Hacettepe University, Ankara, Turkiye.ORCID https://orcid.org/0000-0002-2603-7587
Sevda F MüftüoğluDepartment of Histology and Embryology, Faculty of Medicine, Hacettepe University, Ankara, Turkiye.ORCID https://orcid.org/0000-0003-0664-0204
Yıldırım SaraDepartment of Medical Pharmacology, Faculty of Medicine, Hacettepe University, Ankara, Turkiye.ORCID https://orcid.org/0000-0003-1079-0782

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background/aim: Peripheral nerve injuries (PNIs) are debilitating disorders affecting predominantly the younger generation, often leading to significant disabilities. Current treatment strategies are inadequate for addressing the complex nature of these injuries. Peripheral nerve healing and functional recovery are crucial components of both pathophysiology and therapeutic approaches. High fructose corn syrup (HFCS) is a sweetener frequently used in several beverages and foods. It is associated with several metabolic disturbances including insulin resistance and may impair nerve healing. This study investigated the therapeutic role of ivermectin on nerve regeneration following sciatic nerve injury and evaluated motor and sensorial functions together with histopathological evaluation. Additionally, we aimed to compare nerve healing between animals that consume HFCS and those that do not. Materials and methods: Forty-eight male Swiss albino mice were randomly divided into six groups, with three consuming HFCS-42 (11% v/v) and the other three regular tap water for 8 weeks. On day 28, sciatic nerve injury (SNI) was caused in all groups. Ivermectin (1 mg/kg) or gabapentin (30 mg/kg) treatments were administered to selected groups. Body weight, blood glucose, motor function (rotarod, open field test), and thermal-mechanical sensorial functions were assessed weekly. Finally, insulin levels were measured and histopathological samples were taken. Results: Eight weeks of HFCS consumption impaired mechanical and thermal sensory functions and resulted in histopathologically poor nerve repair. Ivermectin resulted in improved sensorial and faster motor function recovery in the HFCS groups. Elevated plasma insulin levels/HOMA-IR values were diminished by ivermectin in the HFCS groups. In the ivermectin non-HFCS group, histopathology revealed accelerated healing and higher scores in total. Ivermectin also ameliorated mechanical sensation loss after SNI along with cold sensation. Conclusion: Ivermectin accelerated sensorial and motor nerve recovery, resulting in faster nerve healing alongside improved insulin resistance, suggesting it might serve as a potential foundation for developing a new treatment for nerve regeneration after injury.

Indexed as

FructoseHigh Fructose Corn SyrupIvermectinNerve RegenerationPeripheral Nerve InjuriesSciatic NerveAnimalsDisease Models, AnimalMaleMiceFructoseHigh Fructose Corn SyrupIvermectinhigh fructose corn syrupivermectinnerve regenerationSciatic nerve

Identifiers

PMID40104317
PMCPMC11913497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.